{"SLR NAME":"Hydroxychloroquine for treatment of nonsevere COVID?19 patients: Systematic review and meta?analysis of controlled clinical trials","References":[{"title1":"Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial","References":[{"title2":"Coronavirus covid-19 global cases by Johns Hopkins CSSE. https://www.arcgis.com/apps/opsdashboard/index.html#/85320e2ea5424dfaaa75ae62e5c06e61.","References":[]},{"title2":"Middle East respiratory syndrome and severe acute respiratory syndrome: current therapeutic options and potential targets for novel therapies","References":[{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"},{"title3":"Middle%20East%20respiratory%20syndrome%20and%20severe%20acute%20respiratory%20syndrome:%20current%20therapeutic%20options%20and%20potential%20targets%20for%20novel%20therapies"}]},{"title2":"A trial of lopinavir-ritonavir in adults hospitalized with severe covid-19","References":[{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20covid-19"},{"title3":"A%20trial%20of%20lopinavir-ritonavir%20in%20adults%20hospitalized%20with%20severe%20covid-19"}]},{"title2":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","References":[{"title3":"Remdesivir%20and%20chloroquine%20effectively%20inhibit%20the%20recently%20emerged%20novel%20coronavirus%20(2019-nCoV)%20in%20vitro"},{"title3":"Remdesivir%20and%20chloroquine%20effectively%20inhibit%20the%20recently%20emerged%20novel%20coronavirus%20(2019-nCoV)%20in%20vitro"}]},{"title2":"In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","References":[]},{"title2":"Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of covid-19 associated pneumonia in clinical studies","References":[]},{"title2":"National Health Commission of the People's Republic of China. Chinese guideline for the management COVID-19 (version 7.0, in Chinese). 2020. http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989/files/ce3e6945832a438eaae415350a8ce964.pdf.","References":[]},{"title2":"US Food and Drug Administration. Emergency Use Authorization. Hydroxychloroquine sulfate health care provider fact sheet. https://www.fda.gov/media/136534/download.","References":[]},{"title2":"Piller C. &quot;This is insane!&quot; Many scientists lament Trump's embrace of risky malaria drugs for coronavirus. 2020. https://www.sciencemag.org/news/2020/03/insane-many-scientists-lament-trump-s-embrace-risky-malaria-drugs-coronavirus#.","References":[]},{"title2":"Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases","References":[]},{"title2":"Covid-19 - the search for effective therapy","References":[{"title3":"Covid-19%20-%20the%20search%20for%20effective%20therapy"},{"title3":"Covid-19%20-%20the%20search%20for%20effective%20therapy"},{"title3":"Covid-19%20-%20the%20search%20for%20effective%20therapy"}]},{"title2":"National Health Commission of the People's Republic of China. Chinese guideline for the management covid-19 (version 5.0, in Chinese). 2020. http://www.nhc.gov.cn/yzygj/s7653p/202002/d4b895337e19445f8d728fcaf1e3e13a/files/ab6bec7f93e64e7f998d802991203cd6.pdf.","References":[]},{"title2":"Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study [correction in: BMJ 2020;368:m1295]","References":[]},{"title2":"Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study","References":[{"title3":"Viral%20load%20dynamics%20and%20disease%20severity%20in%20patients%20infected%20with%20SARS-CoV-2%20in%20Zhejiang%20province,%20China,%20January-March%202020:%20retrospective%20cohort%20study"},{"title3":"Viral%20load%20dynamics%20and%20disease%20severity%20in%20patients%20infected%20with%20SARS-CoV-2%20in%20Zhejiang%20province,%20China,%20January-March%202020:%20retrospective%20cohort%20study"},{"title3":"Viral%20load%20dynamics%20and%20disease%20severity%20in%20patients%20infected%20with%20SARS-CoV-2%20in%20Zhejiang%20province,%20China,%20January-March%202020:%20retrospective%20cohort%20study"},{"title3":"Viral%20load%20dynamics%20and%20disease%20severity%20in%20patients%20infected%20with%20SARS-CoV-2%20in%20Zhejiang%20province,%20China,%20January-March%202020:%20retrospective%20cohort%20study"},{"title3":"Viral%20load%20dynamics%20and%20disease%20severity%20in%20patients%20infected%20with%20SARS-CoV-2%20in%20Zhejiang%20province,%20China,%20January-March%202020:%20retrospective%20cohort%20study"},{"title3":"Viral%20load%20dynamics%20and%20disease%20severity%20in%20patients%20infected%20with%20SARS-CoV-2%20in%20Zhejiang%20province,%20China,%20January-March%202020:%20retrospective%20cohort%20study"},{"title3":"Viral%20load%20dynamics%20and%20disease%20severity%20in%20patients%20infected%20with%20SARS-CoV-2%20in%20Zhejiang%20province,%20China,%20January-March%202020:%20retrospective%20cohort%20study"},{"title3":"Viral%20load%20dynamics%20and%20disease%20severity%20in%20patients%20infected%20with%20SARS-CoV-2%20in%20Zhejiang%20province,%20China,%20January-March%202020:%20retrospective%20cohort%20study"},{"title3":"Viral%20load%20dynamics%20and%20disease%20severity%20in%20patients%20infected%20with%20SARS-CoV-2%20in%20Zhejiang%20province,%20China,%20January-March%202020:%20retrospective%20cohort%20study"},{"title3":"Viral%20load%20dynamics%20and%20disease%20severity%20in%20patients%20infected%20with%20SARS-CoV-2%20in%20Zhejiang%20province,%20China,%20January-March%202020:%20retrospective%20cohort%20study"},{"title3":"Viral%20load%20dynamics%20and%20disease%20severity%20in%20patients%20infected%20with%20SARS-CoV-2%20in%20Zhejiang%20province,%20China,%20January-March%202020:%20retrospective%20cohort%20study"},{"title3":"Viral%20load%20dynamics%20and%20disease%20severity%20in%20patients%20infected%20with%20SARS-CoV-2%20in%20Zhejiang%20province,%20China,%20January-March%202020:%20retrospective%20cohort%20study"},{"title3":"Viral%20load%20dynamics%20and%20disease%20severity%20in%20patients%20infected%20with%20SARS-CoV-2%20in%20Zhejiang%20province,%20China,%20January-March%202020:%20retrospective%20cohort%20study"},{"title3":"Viral%20load%20dynamics%20and%20disease%20severity%20in%20patients%20infected%20with%20SARS-CoV-2%20in%20Zhejiang%20province,%20China,%20January-March%202020:%20retrospective%20cohort%20study"},{"title3":"Viral%20load%20dynamics%20and%20disease%20severity%20in%20patients%20infected%20with%20SARS-CoV-2%20in%20Zhejiang%20province,%20China,%20January-March%202020:%20retrospective%20cohort%20study"},{"title3":"Viral%20load%20dynamics%20and%20disease%20severity%20in%20patients%20infected%20with%20SARS-CoV-2%20in%20Zhejiang%20province,%20China,%20January-March%202020:%20retrospective%20cohort%20study"},{"title3":"Viral%20load%20dynamics%20and%20disease%20severity%20in%20patients%20infected%20with%20SARS-CoV-2%20in%20Zhejiang%20province,%20China,%20January-March%202020:%20retrospective%20cohort%20study"},{"title3":"Viral%20load%20dynamics%20and%20disease%20severity%20in%20patients%20infected%20with%20SARS-CoV-2%20in%20Zhejiang%20province,%20China,%20January-March%202020:%20retrospective%20cohort%20study"},{"title3":"Viral%20load%20dynamics%20and%20disease%20severity%20in%20patients%20infected%20with%20SARS-CoV-2%20in%20Zhejiang%20province,%20China,%20January-March%202020:%20retrospective%20cohort%20study"},{"title3":"Viral%20load%20dynamics%20and%20disease%20severity%20in%20patients%20infected%20with%20SARS-CoV-2%20in%20Zhejiang%20province,%20China,%20January-March%202020:%20retrospective%20cohort%20study"},{"title3":"Viral%20load%20dynamics%20and%20disease%20severity%20in%20patients%20infected%20with%20SARS-CoV-2%20in%20Zhejiang%20province,%20China,%20January-March%202020:%20retrospective%20cohort%20study"},{"title3":"Viral%20load%20dynamics%20and%20disease%20severity%20in%20patients%20infected%20with%20SARS-CoV-2%20in%20Zhejiang%20province,%20China,%20January-March%202020:%20retrospective%20cohort%20study"},{"title3":"Viral%20load%20dynamics%20and%20disease%20severity%20in%20patients%20infected%20with%20SARS-CoV-2%20in%20Zhejiang%20province,%20China,%20January-March%202020:%20retrospective%20cohort%20study"},{"title3":"Viral%20load%20dynamics%20and%20disease%20severity%20in%20patients%20infected%20with%20SARS-CoV-2%20in%20Zhejiang%20province,%20China,%20January-March%202020:%20retrospective%20cohort%20study"},{"title3":"Viral%20load%20dynamics%20and%20disease%20severity%20in%20patients%20infected%20with%20SARS-CoV-2%20in%20Zhejiang%20province,%20China,%20January-March%202020:%20retrospective%20cohort%20study"},{"title3":"Viral%20load%20dynamics%20and%20disease%20severity%20in%20patients%20infected%20with%20SARS-CoV-2%20in%20Zhejiang%20province,%20China,%20January-March%202020:%20retrospective%20cohort%20study"},{"title3":"Viral%20load%20dynamics%20and%20disease%20severity%20in%20patients%20infected%20with%20SARS-CoV-2%20in%20Zhejiang%20province,%20China,%20January-March%202020:%20retrospective%20cohort%20study"},{"title3":"Viral%20load%20dynamics%20and%20disease%20severity%20in%20patients%20infected%20with%20SARS-CoV-2%20in%20Zhejiang%20province,%20China,%20January-March%202020:%20retrospective%20cohort%20study"},{"title3":"Viral%20load%20dynamics%20and%20disease%20severity%20in%20patients%20infected%20with%20SARS-CoV-2%20in%20Zhejiang%20province,%20China,%20January-March%202020:%20retrospective%20cohort%20study"},{"title3":"Viral%20load%20dynamics%20and%20disease%20severity%20in%20patients%20infected%20with%20SARS-CoV-2%20in%20Zhejiang%20province,%20China,%20January-March%202020:%20retrospective%20cohort%20study"},{"title3":"Viral%20load%20dynamics%20and%20disease%20severity%20in%20patients%20infected%20with%20SARS-CoV-2%20in%20Zhejiang%20province,%20China,%20January-March%202020:%20retrospective%20cohort%20study"},{"title3":"Viral%20load%20dynamics%20and%20disease%20severity%20in%20patients%20infected%20with%20SARS-CoV-2%20in%20Zhejiang%20province,%20China,%20January-March%202020:%20retrospective%20cohort%20study"},{"title3":"Viral%20load%20dynamics%20and%20disease%20severity%20in%20patients%20infected%20with%20SARS-CoV-2%20in%20Zhejiang%20province,%20China,%20January-March%202020:%20retrospective%20cohort%20study"},{"title3":"Viral%20load%20dynamics%20and%20disease%20severity%20in%20patients%20infected%20with%20SARS-CoV-2%20in%20Zhejiang%20province,%20China,%20January-March%202020:%20retrospective%20cohort%20study"},{"title3":"Viral%20load%20dynamics%20and%20disease%20severity%20in%20patients%20infected%20with%20SARS-CoV-2%20in%20Zhejiang%20province,%20China,%20January-March%202020:%20retrospective%20cohort%20study"}]},{"title2":"Seasonal influenza in adults and children-diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America","References":[]},{"title2":"Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis","References":[]},{"title2":"Rapid onset of retinal toxicity from high-dose hydroxychloroquine given for cancer therapy","References":[]},{"title2":"An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists","References":[]},{"title2":"Oral erythromycin and the risk of sudden death from cardiac causes","References":[]},{"title2":"Antimicrobial-associated QT interval prolongation: pointes of interest","References":[]},{"title2":"Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology","References":[]},{"title2":"Detection of SARS-CoV-2 in different types of clinical specimens","References":[{"title3":"Detection%20of%20SARS-CoV-2%20in%20different%20types%20of%20clinical%20specimens"},{"title3":"Detection%20of%20SARS-CoV-2%20in%20different%20types%20of%20clinical%20specimens"},{"title3":"Detection%20of%20SARS-CoV-2%20in%20different%20types%20of%20clinical%20specimens"},{"title3":"Detection%20of%20SARS-CoV-2%20in%20different%20types%20of%20clinical%20specimens"},{"title3":"Detection%20of%20SARS-CoV-2%20in%20different%20types%20of%20clinical%20specimens"},{"title3":"Detection%20of%20SARS-CoV-2%20in%20different%20types%20of%20clinical%20specimens"},{"title3":"Detection%20of%20SARS-CoV-2%20in%20different%20types%20of%20clinical%20specimens"},{"title3":"Detection%20of%20SARS-CoV-2%20in%20different%20types%20of%20clinical%20specimens"},{"title3":"Detection%20of%20SARS-CoV-2%20in%20different%20types%20of%20clinical%20specimens"},{"title3":"Detection%20of%20SARS-CoV-2%20in%20different%20types%20of%20clinical%20specimens"},{"title3":"Detection%20of%20SARS-CoV-2%20in%20different%20types%20of%20clinical%20specimens"},{"title3":"Detection%20of%20SARS-CoV-2%20in%20different%20types%20of%20clinical%20specimens"},{"title3":"Detection%20of%20SARS-CoV-2%20in%20different%20types%20of%20clinical%20specimens"},{"title3":"Detection%20of%20SARS-CoV-2%20in%20different%20types%20of%20clinical%20specimens"},{"title3":"Detection%20of%20SARS-CoV-2%20in%20different%20types%20of%20clinical%20specimens"},{"title3":"Detection%20of%20SARS-CoV-2%20in%20different%20types%20of%20clinical%20specimens"},{"title3":"Detection%20of%20SARS-CoV-2%20in%20different%20types%20of%20clinical%20specimens"},{"title3":"Detection%20of%20SARS-CoV-2%20in%20different%20types%20of%20clinical%20specimens"}]}]}]}